Edit |   |
---|---|
Antigenic Specificity | CD326, Human (Tucotuzumab biosimilar) |
Clone | Tucotuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD326 Recombinant Antibody (Tucotuzumab). Tucotuzumab celmoleukin is an anti-cancer drug. It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin). This drug was developed by EMD Pharmaceuticals. |
Immunogen | n/a |
Other Names | Anti-CD326 Recombinant Antibody, Research Grade Tucotuzumab, Anti-Human CD326 Recombinant Antibody(Tucotuzumab), EMD 273066, KSA-Interleukin-2, Antibody Drug Analogues, Monoclonal Antibody, YR1166, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 339986-90-2 |
Catalog # | YR1166 |
Price | please inquire |
Order / More Info | CD326, Human (Tucotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |